The Role of Insulin in Critically Ill Patient: Basic and Clinical Evidence
Natcher Conference Center
Main Auditorium
National Institutes of Health
Bethesda, Maryland
December 9, 2004
Summary
Emerging information from different basic and clinical arenas has centered attention on the crucial role of insulin during stress and in particular in the acutely ill patient. Elegant clinical studies indicate that aggressive glucose control reduces mortality, while the role of insulin, independent of glucose control, is also being evaluated. The purpose of this meeting is to review the most currently relevant information assessing insulin therapy in the acutely ill as well as to explore the potential underlying mechanisms involved in these processes.
Preliminary Program
Thursday, December 9, 2004
7:30 am
Registration
8:20 am
Welcome and Introduction
Allen M. Spiegel, MD
SESSION I: CLINICAL SCIENCE
Chairs: Claresa Levetan, MD and Howard Baum, MD
8:30 - 9:05 am
Intensive insulin therapy in the ICU
Greet Van den Berghe, MD, PhD
9:05 - 9:10 am
Questions and Answers
9:10 - 9.45 am
Glucose regulation in diabetic patients with acute coronary syndromes
Klas Malmberg, MD, PhD
9:45 - 9:50 pm
Questions and Answers
9:50 - 10:20 am
BREAK
10:20 - 10:55 am
Clinical experience of implementing tight glucose control
Jeremy Cordingley, MD
10:55 - 11:00 am
Questions and Answers
11:00 - 11:35 am
The impact of hyperglycemia and insulin infusions on cardiac surgery outcomes: The Portland Diabetic Project
Anthony Furnary, MD
11:35 - 11:40 am
Questions and Answers
11:40 - 12:40 pm
LUNCH
SESSION II: BASIC SCIENCE
Chairs: R. Smith, MD and Nathaniel Clark, MD
12:40 - 1:20 pm
The anti-inflammatory and anti-atherogenic effect of insulin!
Paresh Dandona, MD, PhD
1:20 - 1:25 pm
Questions and Answers
1:25 - 2:05 pm
Pro-atherosclerotic effects of insulin resistance and hyperinsulinemia
Boris Draznin, MD
2:05 - 2:10 pm
Questions and Answers
2:10 - 2:25 pm
BREAK
2:25 - 3.05 pm
Endothelial NO
Michael Quon, MD, PhD
3:05 - 3:10pm
Questions and Answers
3:10 - 3:50 pm
Nuclear receptors in the etiology and treatment of Syndrome X
Ronald Evans, PhD
3:50 - 3:55 pm
Questions and Answers
3:55 - 4:10 pm
Summary
Jesse Roth, MD
4:10 - 5:10 pm
Roundtable discussion
Speakers
Howard Baum, MD
Dallas Diabetes and Endocrinology Center
Nathaniel Clark, MD
American Diabetes Association
Jeremy Cordingley, MD
Royal Brompton Hospital
Paresh Dandona, MD, PhD
State University of New York, Buffalo
Boris Draznin, MD
ACOS VA Hosiptal
Ronald M. Evans, PhD
SALK Institute for Biological Studies
Anthony Furnary, MD
Starr Wood Group
Claresa Levetan, MD
MCP Hospital
Klas Malmberg, MD, PhD
Karolinska Hospital
Michael Quon, MD, PhD
National Institutes of Health
Jesse Roth, MD
North Shore Hospital
Robert Smith, MD
Rhode Island Hospital
Greet Van den Berghe, MD, PhD
University Hospital Gasthuisberg
Page last updated: November 05, 2010
